Frequency of Mutations Associated with Resistance to First- and Second-Line Drugs in Multidrug Resistant Mycobacterium Tuberculosis Isolates
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F20%3A10410202" target="_blank" >RIV/00216208:11140/20:10410202 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/62157124:16810/20:43879031
Výsledek na webu
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=26g-E55xnk" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=26g-E55xnk</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jgar.2020.03.013" target="_blank" >10.1016/j.jgar.2020.03.013</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Frequency of Mutations Associated with Resistance to First- and Second-Line Drugs in Multidrug Resistant Mycobacterium Tuberculosis Isolates
Popis výsledku v původním jazyce
INTRODUCTION: Tuberculosis (TB) is considered one of the most fatal diseases worldwide with an estimation of 10.1 million cases (WHO 2018). In this study, Whole genome sequencing (WGS) was used to perform genomic characterization of 40 Mycobacterium tuberculosis (M. tuberculosis) isolates from patients with different nationalities hospitalized in the Czech Republic. MATERIALS AND METHODS: Susceptibility testing for first line drugs was performed. DNA was sequenced using Illumina MiSeq platform. Spoligotypes Single Nucleotide Polymorphisms (SNPs) and mutations in antibiotic resistant genes were detected and phylogenetic analysis was performed. RESULTS: Samples showing phenotypic resistance to at least one drug were 12 to streptomycin, 11 to isoniazid, seven to rifampicin, six to ethambutol and five to pyrazinamide. Phenotypic and genotypic profiles didn't match in all cases suggesting the presence of novel mutation in some cases and low expression of resistant genes in others. The presented phylogeny enables the correct assignation of M. tuberculosis lineages and sub-lineages. Our results suggest that the most dominant lineage in our samples was lineages 4 (33/40). CONCLUSION: To our knowledge, this is the first study using this approach to be done in Czech Republic. Lineage 4 was the predominant lineage identified among our samples. Nevertheless, the dominance of Lineage 4 along with other lineages suggests that infections can be originated from different sources.
Název v anglickém jazyce
Frequency of Mutations Associated with Resistance to First- and Second-Line Drugs in Multidrug Resistant Mycobacterium Tuberculosis Isolates
Popis výsledku anglicky
INTRODUCTION: Tuberculosis (TB) is considered one of the most fatal diseases worldwide with an estimation of 10.1 million cases (WHO 2018). In this study, Whole genome sequencing (WGS) was used to perform genomic characterization of 40 Mycobacterium tuberculosis (M. tuberculosis) isolates from patients with different nationalities hospitalized in the Czech Republic. MATERIALS AND METHODS: Susceptibility testing for first line drugs was performed. DNA was sequenced using Illumina MiSeq platform. Spoligotypes Single Nucleotide Polymorphisms (SNPs) and mutations in antibiotic resistant genes were detected and phylogenetic analysis was performed. RESULTS: Samples showing phenotypic resistance to at least one drug were 12 to streptomycin, 11 to isoniazid, seven to rifampicin, six to ethambutol and five to pyrazinamide. Phenotypic and genotypic profiles didn't match in all cases suggesting the presence of novel mutation in some cases and low expression of resistant genes in others. The presented phylogeny enables the correct assignation of M. tuberculosis lineages and sub-lineages. Our results suggest that the most dominant lineage in our samples was lineages 4 (33/40). CONCLUSION: To our knowledge, this is the first study using this approach to be done in Czech Republic. Lineage 4 was the predominant lineage identified among our samples. Nevertheless, the dominance of Lineage 4 along with other lineages suggests that infections can be originated from different sources.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10606 - Microbiology
Návaznosti výsledku
Projekt
Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Global Antimicrobial Resistance
ISSN
2213-7165
e-ISSN
—
Svazek periodika
22
Číslo periodika v rámci svazku
September
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
8
Strana od-do
275-282
Kód UT WoS článku
000572257300037
EID výsledku v databázi Scopus
2-s2.0-85087002151